466,272 DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Private Management Group Inc.

Key Points

• Private Management Group increased its DENTSPLY SIRONA stake by 18.9%, adding 466,272 shares and ending the quarter with nearly 2.94 million shares, worth about $26 million.
• The company missed quarterly expectations, reporting EPS of $0.29 versus $0.31 expected and revenue of $836 million versus $861.7 million expected; revenue fell 7.5% year over year.
• Analysts’ consensus rating is Hold, with an average price target of $12.42. The stock opened at $9.54 in the reported session.

Private Management Group Inc. increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 18.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,936,998 shares of the medical instruments supplier's stock after buying an additional 466,272 shares during the quarter. Private Management Group Inc. owned about 1.47% of DENTSPLY SIRONA worth $26,022,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Paradigm Capital Management Inc. NY bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth $39,775,000. The Manufacturers Life Insurance Company bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $1,956,000. BlackRock Inc. bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $283,405,000. Bank of New York Mellon Corp bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $16,408,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new stake in shares of DENTSPLY SIRONA in the second quarter worth approximately $47,780,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Up 0.8%

XRAY opened at $9.54 on Tuesday. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of 7.45, a PEG ratio of 1.37 and a beta of 0.87. DENTSPLY SIRONA Inc. has a twelve month low of $8.14 and a twelve month high of $14.76. The company's 50-day moving average price is $9.57 and its two-hundred day moving average price is $11.26.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.31 by ($0.02). The company had revenue of $836.00 million for the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm's revenue was down 7.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.33 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Barrington Research dropped their target price on DENTSPLY SIRONA from $15.00 to $13.00 and set an "outperform" rating on the stock in a report on Monday, October 26th. Mizuho decreased their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating for the company in a report on Thursday, October 22nd. Bank of America reiterated a "buy" rating on shares of DENTSPLY SIRONA in a report on Friday. BMO Capital Markets lowered their price target on DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating for the company in a research report on Thursday, September 17th. Finally, Piper Sandler dropped their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating on the stock in a research note on Friday, October 9th. Three investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $12.42.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care.

The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

DENTSPLY SIRONA was formed in 2016 through the merger of DENTSPLY International and Sirona Dental Systems, bringing together businesses with long histories in dental products and equipment.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.